1. Home
  2. OPK vs IHS Comparison

OPK vs IHS Comparison

Compare OPK & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • IHS
  • Stock Information
  • Founded
  • OPK 2007
  • IHS 2001
  • Country
  • OPK United States
  • IHS United Kingdom
  • Employees
  • OPK N/A
  • IHS N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • IHS Telecommunications Equipment
  • Sector
  • OPK Health Care
  • IHS Telecommunications
  • Exchange
  • OPK Nasdaq
  • IHS Nasdaq
  • Market Cap
  • OPK 1.0B
  • IHS 2.4B
  • IPO Year
  • OPK 1995
  • IHS 2021
  • Fundamental
  • Price
  • OPK $1.38
  • IHS $7.17
  • Analyst Decision
  • OPK Buy
  • IHS Strong Buy
  • Analyst Count
  • OPK 4
  • IHS 7
  • Target Price
  • OPK $2.75
  • IHS $10.18
  • AVG Volume (30 Days)
  • OPK 1.9M
  • IHS 505.4K
  • Earning Date
  • OPK 11-06-2025
  • IHS 11-11-2025
  • Dividend Yield
  • OPK N/A
  • IHS N/A
  • EPS Growth
  • OPK N/A
  • IHS N/A
  • EPS
  • OPK N/A
  • IHS 0.33
  • Revenue
  • OPK $664,029,000.00
  • IHS $1,731,025,000.00
  • Revenue This Year
  • OPK N/A
  • IHS $1.97
  • Revenue Next Year
  • OPK $0.84
  • IHS $5.50
  • P/E Ratio
  • OPK N/A
  • IHS $21.85
  • Revenue Growth
  • OPK N/A
  • IHS N/A
  • 52 Week Low
  • OPK $1.11
  • IHS $2.44
  • 52 Week High
  • OPK $2.04
  • IHS $7.66
  • Technical
  • Relative Strength Index (RSI)
  • OPK 50.29
  • IHS 52.54
  • Support Level
  • OPK $1.34
  • IHS $7.13
  • Resistance Level
  • OPK $1.44
  • IHS $7.66
  • Average True Range (ATR)
  • OPK 0.04
  • IHS 0.24
  • MACD
  • OPK -0.00
  • IHS -0.03
  • Stochastic Oscillator
  • OPK 40.00
  • IHS 33.11

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

Share on Social Networks: